A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)

A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)

NCT01994837 ·Status: COMPLETED ·Phase: PHASE2

Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

NCT06045819 ·Status: RECRUITING

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415 ·Status: COMPLETED

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

NCT04813263 ·Status: COMPLETED

Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia

NCT03844815 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

NCT05918198 ·Status: RECRUITING ·Phase: PHASE2

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

NCT06030089 ·Status: COMPLETED ·Phase: NA

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

NCT04826523 ·Status: COMPLETED

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

NCT06191263 ·Status: RECRUITING ·Phase: PHASE2

Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

NCT03319901 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

NCT05317494 ·Status: RECRUITING

A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03441555 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05105841 ·Status: COMPLETED ·Phase: PHASE2

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352 ·Status: COMPLETED ·Phase: PHASE3

Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

NCT03415035 ·Status: ACTIVE_NOT_RECRUITING

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

NCT03310190 ·Status: COMPLETED

A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

NCT03625505 ·Status: COMPLETED ·Phase: PHASE1

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

NCT05342584 ·Status: RECRUITING ·Phase: PHASE1

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

NCT02141282 ·Status: COMPLETED ·Phase: PHASE2

A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia

NCT01685892 ·Status: COMPLETED ·Phase: PHASE1

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT03797261 ·Status: TERMINATED ·Phase: PHASE1

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

NCT04509622 ·Status: COMPLETED ·Phase: PHASE3

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3